Pancreatic Stents for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 11, 2007, Pages 1354-1365

  Freeman, Martin L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVICE REMOVAL; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; META ANALYSIS; PANCREAS DUCT; PANCREATIC STENT; PANCREATITIS; PATHOGENICITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT INDICATION; VATER PAPILLA STENOSIS;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FOREIGN-BODY MIGRATION; HUMANS; PANCREATIC DUCTS; PANCREATITIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS;

EID: 35549000027     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.09.007     Document Type: Review

References (72)

1. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37 (1991) 383-393
2. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
3. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
4. Andriulli A., Clemente R., Solmi L., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
5. Boender J., Nix G.A., de Ridder M.A., et al. Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate. Endoscopy 26 (1994) 209-216
6. Chen Y.K., Foliente R.L., Santoro M.J., et al. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 89 (1994) 327-333
7. Christoforidis E., Goulimaris I., Kanellos I., et al. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy 34 (2002) 286-292
8. Friedland S., Soetikno R.M., Vandervoort J., et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 34 (2002) 483-488
9. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48 (1998) 1-10
10. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
11. Mehta S.N., Pavone E., Barkun J.S., et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 30 (1998) 457-463
12. Rabenstein T., Schneider H.T., Bulling D., et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 32 (2000) 10-19
13. Sherman S., Ruffolo T.A., Hawes R.H., et al. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 101 (1991) 1068-1075
14. Tzovaras G., Shukla P., Kow L., et al. What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography?. Aust N Z J Surg 70 (2000) 778-782
15. Vandervoort J., Soetikno R.M., Tham T.C., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 56 (2002) 652-656
16. Tarnasky P., Cunningham J., Cotton P., et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 29 (1997) 252-257
17. Cheon Y.K., Cho K.B., Watkins J.B., et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc 65 (2007) 385-393
18. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101 (2006) 139-147
19. Masci E., Mariani A., Curioni S., et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35 (2003) 830-834
20. Freeman M.L., and Guda N.M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59 (2004) 845-864
21. Singh P., Gurudu S.R., Davidoff S., et al. Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 59 (2004) 499-505
22. DiSario J.A., Freeman M., Bjorkman D., et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127 (2004) 1291-1299
23. Baron T., and Harewood G.C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized controlled trials. Am J Gastroenterol 99 (2004) 1455-1460
24. Weinberg B.M., Shindy W., and Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev 18 (2006) CD004890
25. Norton I.D., Gostout C.J., Baron T.H., et al. Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 56 (2002) 239-243
26. Desilets D.J., Dy R.M., Ku P.M., et al. Endoscopic management of tumors of the major duodenal papilla: refined techniques to improve outcome and avoid complications. Gastrointest Endosc 54 (2001) 202-208
27. Catalano M.F., Linder J.D., Chak A., et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 59 (2004) 225-232
28. Cheng C.L., Sherman S., Fogel E.L., et al. Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc 60 (2004) 756-757
29. Banks P., and Freeman M.L. Guidelines for management of acute pancreatitis. Am J Gastroenterol 101 (2006) 2379-2400
30. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39 (1993) 652-657
31. Sherman S., Earle D.T., Bucksot L., et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis?. A final analysis of a randomized prospective study (abstr). Gastrointest Endosc 43 (1996) A489
32. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115 (1998) 1518-1524
33. Patel R., Tarnasky P., Hennessy W.S., et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy?. Preliminary results of a prospective randomized trial (abstr). Gastrointest Endosc 49 (1999) AB80
34. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc 57 (2003) 291-294
35. Harewood G.C., Pochron N.L., and Gostout C.J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 62 (2005) 367-370
36. Sofuni A., Maguchi H., Itoi K., et al. Prophylaxis of post-ERCP pancreatitis by an endoscopic pancreatic spontaneous dislodgement. Clin Gastroenterol Hepatol 5 (2007) 1339-1346
37. Elton E., Howell D.A., Parsons W.G., et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 47 (1998) 240-249
38. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 49 (1999) 322-327
39. Aizawa T., and Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 54 (2001) 209-213
40. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34 (2002) 280-285
41. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 5 (2004) 8-14
42. Hookey L.C., RioTinto R., Delhaye M., et al. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases. Endoscopy 38 (2006) 670-676
43. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
44. Brackbill S., Young S., Schoenfeld P., et al. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc 64 (2006) 45-51
45. Das A., Singh P., Sivak M.V., et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 65 (2007) 960-968
46. Attwell A., Borak G., Hawes R., et al. Endoscopic pancreatic sphincterotomy for pancreas divisum by using a needle-knife or standard pull-type technique: safety and reintervention rates. Gastrointest Endosc 64 (2006) 705-711
47. Varadarajulu S., and Wilcox C.M. Randomized trial comparing needle-knife and pull-sphincterotome techniques for pancreatic sphincterotomy in high-risk patients. Gastrointest Endosc 64 (2006) 716-722
48. Tarnasky P.R. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications. JOP 4 (2003) 58-67
49. Gottlieb K., Sherman S., Pezzi J., et al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 91 (1996) 1553-1557
50. Testoni P.A., Bagnolo F., Caporuscio S., et al. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 94 (1999) 1235-1241
51. Kozarek R.A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 36 (1990) 93-95
52. Siegel J., and Veerappan A. Endoscopic management of pancreatic disorders: potential risks of pancreatic prostheses. Endoscopy 23 (1991) 177-180
53. Sherman S., Alvarez C., Robert M., et al. Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas. Gastrointest Endosc 39 (1993) 658-664
54. Sherman S., Hawes R.H., Savides T.J., et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 44 (1996) 276-282
55. Smith M.T., Sherman S., Ikenberry S.O., et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 44 (1996) 268-275
56. Rashdan A., Fogel E.L., McHenry Jr. L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329
57. Raju G.S., Gomez G., Xiao S.Y., et al. Effect of a novel pancreatic stent design on short-term pancreatic injury in a canine model. Endoscopy 38 (2006) 260-265
58. Johanson J.F., Schmalz M.J., and Geenen J.E. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 38 (1992) 341-346
59. Johanson J.F., Schmalz M.J., and Geenen J.E. Simple modification of a pancreatic duct stent to prevent proximal migration. Gastrointest Endosc 39 (1993) 62-64
60. Cohen S.A., Kasmin F.E., and Siegel J.H. Alterations of pancreatic stents. Gastrointest Endosc 40 (1994) 256-257
61. Waxman I., Fockens P., Huibregtse K., et al. Removal of a broken pancreatic stent using a new stent retrieval device. Gastrointest Endosc 37 (1991) 631-632
62. Dean J.W., Trerotola S.O., and Lehman G.A. Combined percutaneous and endoscopic removal of a proximally migrated pancreatic stent. J Vasc Interv Radiol 7 (1996) 935-938
63. Lahoti S., Catalano M.F., Geenen J.E., et al. Endoscopic retrieval of proximally migrated biliary and pancreatic stents: experience of a large referral center. Gastrointest Endosc 47 (1998) 486-491
64. Baron T.H., Dean L.S., Morgan D.E., et al. Proximal migration of a pancreatic duct stent: endoscopic retrieval using interventional cardiology accessories. Gastrointest Endosc 50 (1999) 124-125
65. Shapiro A.M., Scudamore C.H., July L.V., et al. Calcific intra-pancreatic embedding of a pancreatic stent necessitating surgical removal-a danger of chronic endoscopic retrograde pancreatic stent placement. Gastrointest Endosc 50 (1999) 860-862
66. Horwhat J.D., Jowell P., and Branch S. Proximal migration of a 3 French pancreatic stent in a patient with pancreas divisum: suggested technique for successful retrieval. JOP 6 (2005) 178-184
67. Chahal P., Baron T.H., Tarnasky P., et al. A prospective multicenter randomized trial of pancreatic duct stents to prevent acute post-ERCP pancreatitis (abstr). Gastrointest Endosc (2007) 65 AB129
68. Guda N.M., Catalano M.F., and Geenen J.E. Post ERCP pancreatitis: differences in outcomes between 3 Fr long Pigtail and modified short 5 Fr Geenen stents: a randomized controlled trial (abstr). Gastrointest Endosc (2007) 65 AB113
69. Cohen S., Bacon B.R., Berlin J.A., et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 56 (2002) 803-809
70. Somogyi L., Chuttani R., Croffie J., et al. Technology status evaluation report: biliary and pancreatic stents. Gastrointest Endosc 63 (2006) 910-917
71. Baillie J. Endoscopic ampullectomy: does pancreatic stent placement make it safer?. Gastrointest Endosc 62 (2005) 371-373
72. Silverman W.B. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain. Gastrointest Endosc 65 (2007) 969-970